Ben Lightburn, Co-Founder & CEO, Filament Health
Arkiveret serie ("Inaktivt feed" status)
When? This feed was archived on May 05, 2024 13:07 (). Last successful fetch was on March 21, 2024 12:08 ()
Why? Inaktivt feed status. Vores servere kunne ikke hente et gyldigt podcast-feed i en længere periode.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 328981805 series 3329935
Tune into today’s podcast to hear from Ben Lightburn, the Co-Founder & CEO of Filament Health.
Listed on the NEO Exchange, Filament Health have many irons in the psychedelic fire, spearheading clinical trials (alongside the University of California, San Francisco), registering a whole host of IP and making strides forward within drug discovery. As a company that favours naturally derived psychedelics, rather than their synthetic counterparts, this is a must listen for anyone with a keen eye on psychedelic medicine!
Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content on the GCI Content Hub: https://contenthub.gcintelligence.com/
87 episoder